MDTN Stock Chart & Stats
$1430.00
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$1,100.00 - $1,909.19
Previous CloseN/A
VolumeN/A
Average Volume (3M)233.00
Market Cap
$1.86T
Enterprise ValueN/A
Total Cash (Recent Filing)$9.22B
Total Debt (Recent Filing)$27.96B
Price to Earnings (P/E)22.2
Beta0.08
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.57
Shares Outstanding1,280,045,200
10 Day Avg. Volume32
30 Day Avg. Volume233
Financial Highlights & Ratios
PEG Ratio6.72
Price to Book (P/B)2.16
Price to Sales (P/S)2.94
P/FCF Ratio19.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MDTN FAQ
What was Medtronic’s price range in the past 12 months?
Medtronic lowest stock price was $1100.00 and its highest was $1909.19 in the past 12 months.
What is Medtronic’s market cap?
Medtronic’s market cap is $1.86T.
When is Medtronic’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Medtronic’s earnings last quarter?
Currently, no data Available
Is Medtronic overvalued?
According to Wall Street analysts Medtronic’s price is currently Undervalued.
Does Medtronic pay dividends?
Medtronic does not currently pay dividends.
What is Medtronic’s EPS estimate?
Medtronic’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medtronic have?
Medtronic has 1,280,045,200 shares outstanding.
What happened to Medtronic’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Medtronic?
Currently, no hedge funds are holding shares in MX:MDTN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medtronic Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
MX:MDTN Sentiment 70%
Sector Average 65%
Sector Average 65%
Insider Transactions
Sold Shares
Worth $5.9M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-7.96%
12-Months-Change
Fundamentals
Return on Equity
3.47%
Trailing 12-Months
Asset Growth
1.47%
Trailing 12-Months
Company Description
Medtronic
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.